Kirkland & Ellis counseled Orion Biotech Opportunities Corp. on the deal. Orion Biotech Opportunities Corp. closed its initial public offering (IPO) of 20,000,000 units at a price of...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised MSD Acquisition Corp. on the deal. MSD Acquisition Corp., a special purpose acquisition company, copleted its initial public offering of 57,500,000 units...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Accelerate Acquisition Corp. on the deal. Accelerate Acquisition Corp., a special purpose acquisition company led by Robert Nardelli, Michael Simoff and Jeffrey...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Lead Edge Growth Opportunities Ltd on the deal. Lead Edge Growth Opportunities Ltd, a special purpose acquisition company, executed its initial public...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis and Walkers advised Vector Acquisition Corporation on the deal, while Goodwin Procter LLP serving as legal counsel to Rocket Lab. Vector Acquisition Corporation...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault, Freshfields Bruckhaus Deringer and Ogier served as legal advisors to Li-Cycle, while Kirkland & Ellis and Stikeman Elliott served as legal advisors to Peridot...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised HealthCor Catalio Acquisition Corp. on the deal. HealthCor Catalio Acquisition Corp., a special purpose acquisition company formed for the purpose of entering...
You must be a Standard 1 Year member to access this content.
